Delivery Order SPE2DX22D0010-SPE2D825FFF03
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Concerta ER Tablets 36mg, with a ceiling value of $22,714.79. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 12, 2025, and represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Concerta ER 36 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $3,836.73 and an ultimate completion date of July 15, 2025. The contract was competitively awarded with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $44,139.22 to AmerisourceBergen Drug Corp for 27mg Concerta ER tablets on June 26, 2025, with completion scheduled for June 27, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with the Defense Logistics Agency. The pharmaceutical products will be delivered to the vendor's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,633.84 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Concerta ER tablets 36mg. This is a firm fixed-price, non-set-aside contract with a completion date of August 7, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, PA. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,205.60 for Concerta ER Tablets 54mg, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under the company's broader relationship with the Defense Logistics Agency. The contract was executed on July 29, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $2,173.82 to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a ceiling value of...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Concerta ER (Extended Release) tablets 36 mg. This firm fixed-price delivery order, valued at approximately $42.9K, represents a non-competitive award under the company's existing Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical. The contract is scheduled for completion by August 1, 2025, with fulfillment occurring at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $18,949.34 on August 12, 2025, for the supply of Concerta ER Tabs 36mg. The contract, which is set to be completed by August 13, 2025, is funded by the Medical Supply Chain, a defense-focused federal agency supporting military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $2,986.52. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award reflecting the vendor's capability to meet federal pharmaceutical procurement requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $27,314.50 for 100 tablets of Concerta ER 54 mg on August 15, 2025, with completion scheduled for August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania....
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FFF03Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $24.8K to supply Concerta ER tablets 36mg. The contract, issued on April 25, 2025, with an ultimate completion date of April 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), a comprehensive $1 billion global pharmaceutical supply vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company has established itself through multiple competitively awarded federal contracts supplying a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across various therapeutic domains. The company's substantial IDC with DLA Troop Support demonstrates its capability to fulfill diverse federal medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a global scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.8k | 4/25/25 |